Kala Pharmaceuticals, Inc.
(NASDAQ : KALA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.07%125.850.6%$872.46m
PFEPfizer Inc.
-0.50%37.170.9%$687.55m
ABBVAbbVie, Inc.
-3.24%87.042.1%$545.80m
MRKMerck & Co., Inc.
-0.20%62.390.6%$544.95m
BMYBristol-Myers Squibb Company
0.36%56.741.4%$318.83m
LLYEli Lilly and Company
-0.88%88.641.0%$257.73m
NVSNovartis AG Sponsored ADR
1.83%82.280.2%$176.80m
AZNAstraZeneca PLC Sponsored ADR
0.50%37.211.3%$135.39m
SNYSanofi Sponsored ADR
1.07%42.360.2%$109.37m
GSKGlaxoSmithKline plc Sponsored ADR
0.07%40.720.2%$83.12m
NVONovo Nordisk A/S Sponsored ADR Class B
1.01%50.320.1%$82.34m
LCILannett Company, Inc.
-1.37%12.6337.9%$7.20m
AKTXAkari Therapeutics Plc Sponsored ADR
1.94%2.101.7%$0.21m
EPIXESSA Pharma Inc
-5.44%3.480.0%$0.03m

Company Profile

Kala Pharmaceuticals, Inc. is a biopharmaceutical company, focused on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Waltham, MA.